Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Procalcitonin-based algorithm reduces unnecessary antibiotic use in acute pancreatitis
A procalcitonin-guided algorithm could reduce the unnecessary use of antibiotics in patients with acute pancreatitis, according to results of the PROCAP trial.
Procalcitonin-based algorithm reduces unnecessary antibiotic use in acute pancreatitis
01 Jan 2023Serine protease inhibition shows promise in COVID-19
The serine protease inhibitor upamostat appears to be beneficial in the treatment of COVID-19 outpatients, being generally tolerable and bringing a rapid resolution of severe symptoms while reducing the incidence of new ones, according to the results of a pilot study.
Serine protease inhibition shows promise in COVID-19
23 Dec 2022Bepirovirsen shows promise in controlling chronic HBV infection
Weekly bepirovirsen treatment may help reduce HBsAg* and hepatitis B virus (HBV) DNA levels in patients with chronic HBV infection, the phase IIb B-Clear study showed.
Bepirovirsen shows promise in controlling chronic HBV infection
19 Dec 2022One in eight adults experiences long COVID
One in every eight individuals who has experienced COVID-19 may have persistent symptoms 3–5 months post-infection, according to an observational study from the Netherlands.
One in eight adults experiences long COVID
18 Dec 2022COVID-19 vaccination boosts mental wellbeing during pandemic
Individuals who have received one or two doses of the COVID-19 vaccinations experience improved mental wellbeing during the pandemic, reports a recent Japan study.
COVID-19 vaccination boosts mental wellbeing during pandemic
15 Dec 2022Pregnant women in ICU for COVID-19 more deprived, less vaccinated
Pregnant or recently pregnant women who needed intensive care admission due to COVID-19 tend to live in poorer areas and are less likely to have been vaccinated, a recent study has found.
Pregnant women in ICU for COVID-19 more deprived, less vaccinated
12 Dec 2022Diabetes and COVID-19: What have we learned so far?
Evidence for excess risk and increased burden of new-onset diabetes among COVID-19 survivors is robust, and most antihyperglycaemic drugs can be used safely during acute COVID-19, with some drugs potentially offering protection against serious complications, according to data presented at 5th EDM HK.